从基因到药物:临床实践中的CYP2C19和药物遗传学
Qamar Shubbar1,2, Aminah Alchakee1,2, Khaled Walid Issa1
1College of Medicine, University of Sharjah, Sharjah, United Arab Emirates.
Frontiers in pharmacology
|February 29, 2024
概括
对CYP2C19基因的基因测试指导药物选择,改善患者的治疗结果并减少药物不良反应. 了解CYP2C19变异使个性化医疗和更安全,更有效的治疗成为可能.
科学领域:
- 药物基因组学 药物基因组学
- 临床药理学 临床药理学
- 遗传学 遗传学 是一个
背景情况:
- CYP2C19基因在代谢许多常见药物的过程中起着至关重要的作用.
- CYP2C19的遗传变异会影响药物的有效性和安全性.
- 药基因组测试在临床实践中越来越多地使用.
研究的目的:
- 审查CYP2C19遗传变异对药物代谢和患者结局的影响.
- 探索CYP2C19在各种医学专业领域的临床意义.
- 突出 CYP2C19 基因定型在个性化医学中的作用.
主要方法:
- 对CYP2C19.19最新研究的文献综述.
- 分析CYP2C19表型及其对药物反应的影响.
- 检查心脏病学,精神病学和胃肠病学中的临床应用.
主要成果:
- 在CYP2C19的遗传变异导致不同的代谢活动和不同的患者反应.
- CYP2C19对不同医学领域的许多药物的疗效和安全性产生影响.
- CYP2C19基因型定制有助于定制药物治疗方案,以改善治疗成功.
结论:
- 通过CYP2C19的基因定型,可以支持针对个性化药物的知情临床决策.
- 了解CYP2C19变异可以优化治疗策略并降低医疗保健成本.
- 整合CYP2C19测试可以推进精准医学并提高患者护理.
相关概念视频
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
137
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
137
Nonlinear Pharmacokinetics: Role of Transporters
50
A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
Polymorphisms occurring in drug transporters can alter...
Polymorphisms occurring in drug transporters can alter...
50
Analysis of Population Pharmacokinetic Data
254
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
254
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
61
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
61
Hepatic Drug Clearance: Role of Transporters
56
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
56
Factors Affecting Drug Biotransformation: Biological
149
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
149


